Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Receptors, Androgen”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT04708431
What this trial is testing

Androgen Receptor, Implications for Health and Wellbeing: Natural History Study of Individuals With Androgen Insensitivity

Who this might be right for
Androgen Insensitivity SyndromeMetabolic Parameters in AIS, CAIS, PAIS and MAISTumor Formation in AIS, CAIS, PAIS and MAIS+1 more
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 650
Testing effectiveness (Phase 2)Looking for participantsNCT04947189
What this trial is testing

Seviteronel in Combination With Chemotherapy in Androgen-receptor Positive Metastatic Triple-negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
St Vincent's Hospital, Sydney 65
Testing effectiveness (Phase 2)Study completedNCT01889238
What this trial is testing

Safety and Efficacy Study of Enzalutamide in Patients With Advanced, Androgen Receptor-Positive, Triple Negative Breast Cancer

Who this might be right for
Advanced, Androgen Receptor Positive Triple Negative Breast Cancer
Pfizer 118
Testing effectiveness (Phase 2)Study completedNCT01988324
What this trial is testing

AR and ER Imaging in Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
University Medical Center Groningen 24
Not applicableWithdrawnNCT03296124
What this trial is testing

Prognostic Value of Androgen Receptor Expression and Mutations Within Oncogenes and Tumor Suppressor Genes in Patients Treated for High Risk Prostate Cancer With Proton Therapy (PRX32)

Who this might be right for
Prostate Cancer
University of Florida
Not applicableLooking for participantsNCT05209243
What this trial is testing

START-MET HS Prostate Cancer. : SbrT & Androgen Receptor Therapy METastatic HSPC

Who this might be right for
Prostate CancerStereotactic Body Radiation Therapy
Instituto de Investigación en Oncología Radioterápica - Fundación Española de Oncología Radioterápic 266
Not applicableStudy completedNCT03433768
What this trial is testing

Androgen Receptor mRNA Expression is Positively Associated With Live Birth in Women Undergoing IVF Independently of the Type of Ovarian Response

Who this might be right for
Androgen Receptor Gene OverexpressionNormal RespondersPoor Ovarian Response+1 more
Aristotle University Of Thessaloniki 67
Not applicableLooking for participantsNCT04944940
What this trial is testing

Clinical, Molecular and Imaging Biomarkers in Spinal and Bulbar Muscular Atrophy (SBMA)

Who this might be right for
Spinal and Bulbar Muscular AtrophyKennedys DiseaseMotor Neuron Disease
National Institute of Neurological Disorders and Stroke (NINDS) 70
Testing effectiveness (Phase 2)Active Not RecruitingNCT06169124
What this trial is testing

Study to Test the Drug Darolutamide Along With the Drugs Leuprolide Acetate and Exemestane in Patients With Recurrent Ovarian Granulosa Cell Tumors

Who this might be right for
Adult Ovarian Granulosa Cell Tumor
National Cancer Institute (NCI) 17
Testing effectiveness (Phase 2)Ended earlyNCT01918306
What this trial is testing

GDC-0941 and Cisplatin in Treating Patients With Androgen Receptor-Negative Triple Negative Metastatic Breast Cancer

Who this might be right for
Estrogen Receptor Negative Breast CancerHuman Epidermal Growth Factor 2 Negative Carcinoma of BreastTriple Negative Breast Cancer+3 more
Vanderbilt-Ingram Cancer Center 11
Not applicableStudy completedNCT05109884
What this trial is testing

Comparison of PET Imaging Patterns With PSMA and AR Expression in Prostate Cancer and Bladder Cancer

Who this might be right for
Prostate Cancer
Medical University of Vienna 10
Not applicableStudy completedNCT06204302
What this trial is testing

An Observational Study to Learn More About the Use of Androgen Receptor Inhibitors and How They Affect Men With Nonmetastatic Prostate Cancer in Routine Medical Care in the United States

Who this might be right for
Non-metastatic Prostate CancerNon-metastatic Castration-resistant Prostate Cancer
Bayer 1,800
Testing effectiveness (Phase 2)Study completedNCT01969578
What this trial is testing

Androgen Deprivation Therapy in Advanced Salivary Gland Cancer

Who this might be right for
Salivary Gland Cancer
European Organisation for Research and Treatment of Cancer - EORTC 149
Large-scale testing (Phase 3)Looking for participantsNCT06592924
What this trial is testing

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

Who this might be right for
Prostate Cancer (Adenocarcinoma)
Canadian Cancer Trials Group 830
Testing effectiveness (Phase 2)Study completedNCT02697032
What this trial is testing

FDHT PET and Bicalutamide in Metastatic Breast Cancer

Who this might be right for
Breast Cancer
University Medical Center Groningen 22
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07592910
What this trial is testing

Mevrometostat With Enzalutamide in People With Prostate Cancer Who Have Previously Received Androgen Receptor Pathway Inhibitor Therapy

Who this might be right for
Metastatic Castrate Resistant Prostate Cancer (mCRPC)Prostate Cancer (Adenocarcinoma)
Prostate Cancer Clinical Trials Consortium 60
Testing effectiveness (Phase 2)Study completedNCT01990209
What this trial is testing

Orteronel as Monotherapy in Patients With Metastatic Breast Cancer (MBC) That Expresses the Androgen Receptor (AR)

Who this might be right for
Metastatic Breast Cancer
SCRI Development Innovations, LLC 71
Testing effectiveness (Phase 2)Study completedNCT05059236
What this trial is testing

Learn How Well Darolutamide Administered Together With Androgen Deprivation Therapy (ADT) Works in Men With Metastatic Hormone-sensitive Prostate Cancer. Results Will be Compared With ADT Alone From a Previously Conducted Study.

Who this might be right for
Metastatic Hormone-sensitive Prostate Cancer
Bayer 223
Large-scale testing (Phase 3)Active Not RecruitingNCT04689828
What this trial is testing

177Lu-PSMA-617 vs. Androgen Receptor-Directed Therapy in the Treatment of Progressive Metastatic Castrate Resistant Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Novartis Pharmaceuticals 469
Testing effectiveness (Phase 2)Active Not RecruitingNCT04090528
What this trial is testing

PTVG-HP DNA Vaccine With or Without pTVG-AR DNA Vaccine and Pembrolizumab in Patients With Castration-Resistant, Metastatic Prostate Cancer

Who this might be right for
Castration-resistant Prostate CancerMetastatic CancerProstate Cancer
University of Wisconsin, Madison 60
Next Page